RBC Europe’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
RBC Europe's BSX Position: Q2 2022 in Review
RBC Europe increased its Boston Scientific (BSX) stake by 1.9% in Q2 2022, buying an estimated $36.4K and bringing the position to 48,285 shares worth $1.8M. The position accounts for 0.09% of the portfolio, ranked #85.
RBC Europe first reported a position in BSX in Q3 2017 and has held it in 20 quarters since. The position peaked at $2.1M in Q1 2022. 879 funds tracked by Wall St. Rank hold BSX as of Q2 2022.
- RBC Europe held 48,285 shares of Boston Scientific worth $1.8M as of Q2 2022.
- RBC Europe bought 895 Boston Scientific shares in Q2 2022, an estimated $36.4K.
- Boston Scientific made up 0.09% of RBC Europe's portfolio in Q2 2022, its #85 holding.
- RBC Europe first reported a position in Boston Scientific in Q3 2017 and has held it in 20 quarters since.
- RBC Europe's Boston Scientific position peaked at $2.1M in Q1 2022.
- 879 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.
Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.